EXPERIENCE OF SURGICAL ORTHOPEDIC TREATMENT IN A PATIENT WITH AN INHIBITORY FORM OF HEMOPHILIA A WHO IS BEING TREATED WITH EMICIZUMAB

被引：0
|
作者：
Polyanskaya, T. [1 ]
Zorenko, V. [1 ]
Karpov, E. [1 ]
Mishin, G. [1 ]
Golobokov, A. [1 ]
Koroleva, A. [1 ]
Gorgodze, L. [1 ]
机构：
[1] Natl Hematol Ctr, Moscow, Russia
来源：
HAEMOPHILIA | 2021年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ABS107
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [21] Unlocking Insights: A Single Centre Patient-Reported Outcome Experience in Patients with Severe Hemophilia a without Inhibitors on Emicizumab
    Blydt-Hansen, Ingrid
    Bech, Michelle
    Al-Housni, Zainab
    Germini, Federico
    Skinner, Mark W.
    Jackson, Shannon
    BLOOD, 2023, 142
  • [22] Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
    Dargaud, Yesim
    Lienhart, Anne
    Janbain, Maissaa
    Le Quellec, Sandra
    Enjolras, Nathalie
    Negrier, Claude
    HAEMATOLOGICA, 2018, 103 (04) : E181 - E183
  • [23] USE OF CRYOPRECIPITATE IN SURGICAL TREATMENT OF SPONTANEOUS RUPTURE OF SPLEEN IN A HEMOPHILIA PATIENT
    GOWDA, M
    VIETTI, T
    TERNBERG, JL
    SURGERY, 1968, 64 (06) : 1119 - &
  • [24] Laboratory response to paradigm change in hemophilia treatment How to monitor patients simultaneously treated with emicizumab and factor VIII concentrate?
    Lambert, Marjan Shafaati
    Bruzelius, Maria
    Soutari, Nida Mahmoud Hourani
    Ranta, Susanna
    Antovic, Jovan P. P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (12) : E248 - E250
  • [25] Treatment of Inhibitory-Hemophilia 40 Years of extensive clinical Experience with FEIBA NF
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (05) : 370 - 370
  • [26] Emicizumab treatment in hemophilia A with inhibitors. A case report and cost-minimization analysis of a non-responder to conventional treatment patient
    Martinez Garcia, M. F.
    Fernandez Caballero, M.
    Juarez Gimenez, J. C.
    Serna Pareja, A.
    Cerda Sabater, M.
    Johansson, E.
    Alvarez Martinez, E.
    Fernandez Sarmiento, C.
    Bosch Albareda, F.
    Santamaria Ortiz, A.
    HAEMOPHILIA, 2019, 25 : 131 - 131
  • [27] Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors
    Osuna, Mitsumasa
    Nakajima, Yuto
    Ogiwara, Kenichi
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (05) : 639 - 644
  • [28] Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors
    Osuna, Mitsumasa
    Nakajima, Yuto
    Ogiwara, Kenichi
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024,
  • [29] Attitudes toward psychiatric drug treatment: the experience of being treated
    Carlos De las Cuevas
    Emilio J. Sanz
    European Journal of Clinical Pharmacology, 2007, 63 : 1063 - 1067
  • [30] Attitudes toward psychiatric drug treatment: the experience of being treated
    de las Cuevas, Carlos
    Sanz, Emilio J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1063 - 1067
12345